It is also under assessment in the Phase II/III waveLINE-003 dose confirmation and expansion trial for relapsed or refractory DLBCL, and in the waveLINE-007 study in conjunction with R-CHP for ...

While the grading scales used were different so no direct ... which is approved for DLBCL and another form of non-Hodgkin’s lymphoma called primary mediastinal large B-cell lymphoma (PMBCL ...

A study has shown that bortezomib can enhance the activity of doxorubicin-based chemotherapy for the treatment of activated B-cell-like (ABC) diffuse large B-cell lymphoma (DLBCL). This ...

Cytokine Release Syndrome, or CRS, of Grade 1 or 2 according to ASTCT grading was observed in 34. ... for the treatment of relapsed or refractory DLBCL after two or more lines of systemic therapy.